Advertisement

Readers like you keep news free for everyone.

More than 5,000 readers have already pitched in to keep free access to The Journal.

For the price of one cup of coffee each week you can help keep paywalls away.

Support us today
Not now
Tuesday 5 December 2023 Dublin: 3°C

# one-shot vaccine

All time
EU regulator says unusual blood clots should be listed as 'very rare side effect' of J&J vaccine
The European Medicines Agency said that the “overall benefits” of the vaccine in preventing Covid-19 outweigh the risks of side effects.
Unusual blood clots should be listed as "very rare side effects" - but the "overall benefits" of the vaccine in preventing Covid-19 outweigh the risks.
Eight rare blood clots with low levels of blood platelets were recorded among over 7 million doses of the J&J vaccine administered in the US.
The statement by the EMA is similar to its conclusion for the Oxford-AstraZeneca vaccine - which NIAC decided to limit to those aged over 60.
EMA decision on Johnson & Johnson will influence whether Ireland spaces out Pfizer vaccine doses